Single technology assessments of medicines
Published:
Changes
Before the authorities decide whether a medicine should receive public funding, it must be assessed whether the costs of using the medicine are reasonably proportionate to its benefits, taking into account the severity of the disease.
New, approved medicines must therefore undergo a single technology technology assessment (STA). In an STA, the health technology developer prepares documentation that is evaluated by Norwegian Medical Products Agency (NOMA).